6 completed, 6 unknown, 2 active not recruiting, 1 suspended. 16 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 16 | Completed 6, Unknown 6, Active not recruiting 2, Suspended 1, Terminated 1 |
| Phase 2 | 3 | Completed 1, Suspended 1, Unknown 1 |
Follow FOLFOX regimen: new trials by email Literature Review of FOLFOX regimen trials Research Report on FOLFOX regimen
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Personalizing Chemotherapy Selection After Surgery for Patients With Stage III Colorectal Cancer Using a Blood Test Capecitabine, Oxaliplatin, Folfirinox - Colorectal Cancer | Phase 3 | Active not recruiting | UNICANCER | 2450 | 2026-07-20 | 2026-07-22 |
| Immunotherapy for Advanced Liver Cancer AlloStim® immunotherapy, FOLFOX regimen, Sorafenib - Hepatocellular Carcinoma | Phase 2 / Phase 3 | Suspended | Mirror Biologics, Inc. | 150 | 2023-08-01 | 2025-10-23 |
| Immunosurveillance for Metastatic Colorectal Cancer Adenorine, Placebo, FOLFOX regimen - Monitoring, Immunologic | Phase 2 / Phase 3 | Completed | MIPO Clinic | 187 | 2022-07-15 | 2026-06-29 |
| Study to Evaluate the Efficacy of FOLFOX + Panitumumab Followed by FOLFIRI + Bevacizumab (Sequence 1) Versus FOLFOX + Bevacizumab Followed by FOLFIRI + Panitumumab (Sequence 2) in Untreated Patients With Wild-type RAS Metastatic, Primary Left-sided, Unresectable Colorectal Cancer FOLFOX regimen, Panitumumab, Bevacizumab - Colorectal Cancer | Phase 3 | Active not recruiting | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | 419 | 2018-10-15 | 2024-10-21 |
| Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil/Leucovorin Versus Sorafenib in Advanced Hepatocellular Carcinoma FOLFOX regimen, Sorafenib 200Mg Tab - Liver Cancer, Hepatic Carcinoma | Phase 3 | Completed | Sun Yat-sen University | 262 | 2017-03-01 | 2020-12-16 |
| Estimate the Efficacy of HD6610 Granule for Oxaliplatin-induced Peripheral Neuropathy FOLFOX regimen, HD6610 Granule, HD6610 Granule placebo - Peripheral Neuropathy | Phase 2 / Phase 3 | Unknown | Jiangsu Province Hospital of Traditional Chinese Medicine | 64 | 2015-08-01 | 2015-12-02 |
| Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer bevacizumab, cetuximab, FOLFIRI regimen - Colorectal Cancer | Phase 3 | Terminated | Alliance for Clinical Trials in Oncology | 340 | 2010-08-01 | 2024-12-27 |
| Combination Chemotherapy for 3 Months or 6 Months in Treating Patients With Stage III Colon Cancer FOLFOX regimen, CAPOX - Colorectal Cancer | Phase 3 | Unknown | GERCOR - Multidisciplinary Oncology Cooperative Group | 2000 | 2009-05-12 | 2023-09-29 |
| PRIME: Panitumumab Randomized Trial In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy Panitumumab, FOLFOX regimen - Metastatic Colorectal Cancer | Phase 3 | Completed | Amgen | 1183 | 2006-08-01 | 2022-11-07 |
| Leucovorin and Fluorouracil With or Without Oxaliplatin Compared to Capecitabine With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer FOLFOX regimen, capecitabine, fluorouracil - Colorectal Cancer | Phase 3 | Completed | Medical Research Council | 460 | 2003-09-01 | 2021-09-27 |
| Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer FOLFOX regimen, fluorouracil, leucovorin calcium - Colorectal Cancer | Phase 3 | Unknown | Sanofi | 2000-10-01 | 2014-01-06 | |
| Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer FOLFOX regimen, fluorouracil, leucovorin calcium - Colorectal Cancer, Metastatic Cancer | Phase 3 | Unknown | European Organisation for Research and Treatment of Cancer - EORTC | 2000-09-01 | 2011-04-18 | |
| Combination Chemotherapy in Treating Patients With Unresectable Metastatic Colorectal Cancer FOLFIRI regimen, FOLFOX regimen, fluorouracil - Colorectal Cancer | Phase 3 | Completed | Medical Research Council | 2000-05-01 | 2013-12-19 | |
| Comparing Two Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer FOLFOX regimen, fluorouracil, leucovorin calcium - Colorectal Cancer | Phase 3 | Unknown | GERCOR - Multidisciplinary Oncology Cooperative Group | 2000-01-01 | 2009-01-13 | |
| Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer FOLFOX regimen, fluorouracil, leucovorin calcium - Colorectal Cancer | Phase 3 | Completed | European Organisation for Research and Treatment of Cancer - EORTC | 554 | 1998-03-01 | 2012-07-02 |
| Combination Chemotherapy in Treating Patients With Recurrent Metastatic Colorectal Cancer FOLFIRI regimen, FOLFOX regimen, fluorouracil - Colorectal Cancer | Phase 3 | Unknown | GERCOR - Multidisciplinary Oncology Cooperative Group | 109 | 1998-01-01 | 2009-01-13 |
Colorectal Neoplasms (14) · Colonic Neoplasms (9) · Rectal Neoplasms (7) · Carcinoma, Hepatocellular (2) · Liver Neoplasms (2) · Neoplasm Metastasis (1) · Neoplasms (1) · Peripheral Nervous System Diseases (1)
GERCOR - Multidisciplinary Oncology Cooperative Group (3) · European Organisation for Research and Treatment of Cancer - EORTC (2) · Medical Research Council (2) · Alliance for Clinical Trials in Oncology (1) · Amgen (1) · Jiangsu Province Hospital of Traditional Chinese Medicine (1) · MIPO Clinic (1) · Mirror Biologics, Inc. (1) · Sanofi (1) · Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) (1) · Sun Yat-sen University (1) · UNICANCER (1)
France (6) · United Kingdom (3) · Austria (2) · Belgium (2) · Canada (2) · China (2) · Germany (2) · Italy (2) · Norway (2) · Portugal (2) · Sweden (2) · United States (2) · Australia (1) · Greece (1) · Hong Kong (1)
Aimery de Gramont, MD (2) · Matthew T. Seymour, MA, MD, FRCP (2) · Alexander Stojadinovic, MD (1) · Alfredo Carrato, MD, PhD (1) · Bernard Nordlinger, MD (1) · Euan T. Walpole, MD (1) · Francis Levi, MD, PhD (1) · Gareth Griffiths (1) · Huo JieGe, M.D. (1) · John N. Primrose, MD (1) · Mace L. Rothenberg, MD, FACP (1) · Philippe Rougier, MD (1) · Thierry Andre, MD (1)
PMID 16877722, PMID 17630037, PMID 18358928, PMID 19554377, PMID 19858398, PMID 19884549, PMID 21570111, PMID 21859417, PMID 22070868, PMID 22314329, PMID 24120480, PMID 26049686, PMID 26342674, PMID 27843597, PMID 28449055, PMID 29620995, PMID 29627309, PMID 30019318, PMID 30614531, PMID 30679026, PMID 31378656, PMID 31515083, PMID 32167864, PMID 34905388, PMID 36306483, PMID 36606664, PMID 39889251, PMID 39903903, PMID 40436447
2009 (1)